ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) COVISHIELD™
QUALITATIVE AND QUANTITATIVE COMPOSITION
One dose (0.5 ml) contains:
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant) 5 × 10 virus particles (vp)
ChAdOx1 nCoV- 19 Corona Virus Vaccine (Recombinant)
*Recombinant, replication-deficient chimpanzee adenovirus vector encoding the SARS-CoV-2 Spike (S) glycoprotein. Produced in genetically modified human embryonic kidney (HEK) 293 cells. This product contains genetically modified organisms (GMOs).
For the full list of excipients, see section 6.1.
Both COVISHIELD™ (manufactured by Serum Institute of India Pvt Ltd) and COVID-19 Vaccine AstraZeneca (manufactured by AstraZeneca) are ChAdOx1 nCoV- 19 Corona Virus Vaccines (Recombinant).